Delivery Order SPE2DB22D2007-SPE2DB24FJ1QU
Award Date
4/17/24
Potential Completion Date
4/18/24
Potential Value
$60K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $39,528.02 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle for...
The Defense Logistics Agency (DLA) awarded a $3,195.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $2,356.10 to Amerisourcebergen Drug Corporation's Corporate Office division. This Firm Fixed Price contract is for the supply of 4564559769 ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product, with a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,387.40 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a prescription medication, with a completion date of June 7, 2024. This award is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a $2,816.86 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of 4,565,699,051 units of the ENGERIX-B 20 MCG/ML SYRNML vaccine. This delivery order was placed against an Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for providing pharmaceutical and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,184.67 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,021,525 units of the ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. The contract has a period of performance through June 28, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $2,685.51 and a completion date of February 12, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $1,294.13, is for the delivery of ENGERIX-B 20 MCG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 28, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,378.20 firm fixed-price delivery order contract is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $3,964.77 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of April 24, 2024 and was awarded on April 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...